nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—lung cancer	0.138	0.512	CbGaD
Enzalutamide—ABCB1—lung cancer	0.132	0.488	CbGaD
Enzalutamide—ALB—Gefitinib—lung cancer	0.0264	0.05	CbGbCtD
Enzalutamide—CYP3A5—Gefitinib—lung cancer	0.0212	0.0402	CbGbCtD
Enzalutamide—CYP3A5—Teniposide—lung cancer	0.0205	0.039	CbGbCtD
Enzalutamide—CYP2C19—Gefitinib—lung cancer	0.0171	0.0324	CbGbCtD
Enzalutamide—CYP2C19—Teniposide—lung cancer	0.0166	0.0314	CbGbCtD
Enzalutamide—ALB—Erlotinib—lung cancer	0.0156	0.0296	CbGbCtD
Enzalutamide—ABCB1—Topotecan—lung cancer	0.0151	0.0286	CbGbCtD
Enzalutamide—CYP2B6—Irinotecan—lung cancer	0.0144	0.0272	CbGbCtD
Enzalutamide—CYP2C9—Gefitinib—lung cancer	0.0142	0.027	CbGbCtD
Enzalutamide—ALB—Irinotecan—lung cancer	0.0141	0.0267	CbGbCtD
Enzalutamide—ABCB1—Gefitinib—lung cancer	0.0138	0.0262	CbGbCtD
Enzalutamide—CYP2C9—Teniposide—lung cancer	0.0138	0.0261	CbGbCtD
Enzalutamide—CYP2D6—Gefitinib—lung cancer	0.013	0.0246	CbGbCtD
Enzalutamide—CYP3A5—Crizotinib—lung cancer	0.013	0.0246	CbGbCtD
Enzalutamide—CYP3A5—Erlotinib—lung cancer	0.0125	0.0238	CbGbCtD
Enzalutamide—CYP2C8—Erlotinib—lung cancer	0.012	0.0228	CbGbCtD
Enzalutamide—CYP2B6—Cisplatin—lung cancer	0.0117	0.0222	CbGbCtD
Enzalutamide—CYP3A5—Paclitaxel—lung cancer	0.0115	0.0218	CbGbCtD
Enzalutamide—CYP3A5—Irinotecan—lung cancer	0.0113	0.0215	CbGbCtD
Enzalutamide—CYP2C8—Paclitaxel—lung cancer	0.011	0.0209	CbGbCtD
Enzalutamide—ABCB1—Vinorelbine—lung cancer	0.0106	0.0201	CbGbCtD
Enzalutamide—CYP2D6—Vinorelbine—lung cancer	0.01	0.019	CbGbCtD
Enzalutamide—CYP3A5—Etoposide—lung cancer	0.00906	0.0172	CbGbCtD
Enzalutamide—CYP3A4—Topotecan—lung cancer	0.00903	0.0171	CbGbCtD
Enzalutamide—CYP2C8—Etoposide—lung cancer	0.00871	0.0165	CbGbCtD
Enzalutamide—ABCB1—Crizotinib—lung cancer	0.00845	0.016	CbGbCtD
Enzalutamide—CYP3A5—Docetaxel—lung cancer	0.00829	0.0157	CbGbCtD
Enzalutamide—CYP3A4—Gefitinib—lung cancer	0.00826	0.0157	CbGbCtD
Enzalutamide—ABCB1—Gemcitabine—lung cancer	0.00826	0.0157	CbGbCtD
Enzalutamide—ABCB1—Erlotinib—lung cancer	0.00815	0.0155	CbGbCtD
Enzalutamide—CYP3A4—Teniposide—lung cancer	0.00801	0.0152	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—lung cancer	0.00784	0.0149	CbGbCtD
Enzalutamide—CYP2C9—Paclitaxel—lung cancer	0.00769	0.0146	CbGbCtD
Enzalutamide—CYP2D6—Erlotinib—lung cancer	0.00768	0.0146	CbGbCtD
Enzalutamide—ABCB1—Paclitaxel—lung cancer	0.00746	0.0142	CbGbCtD
Enzalutamide—ALB—Methotrexate—lung cancer	0.00745	0.0141	CbGbCtD
Enzalutamide—ABCB1—Irinotecan—lung cancer	0.00736	0.014	CbGbCtD
Enzalutamide—ABCB1—Vinblastine—lung cancer	0.00654	0.0124	CbGbCtD
Enzalutamide—CYP3A4—Vinorelbine—lung cancer	0.00636	0.0121	CbGbCtD
Enzalutamide—CYP2C9—Cisplatin—lung cancer	0.00618	0.0117	CbGbCtD
Enzalutamide—CYP2D6—Vinblastine—lung cancer	0.00617	0.0117	CbGbCtD
Enzalutamide—ABCB1—Cisplatin—lung cancer	0.006	0.0114	CbGbCtD
Enzalutamide—ABCB1—Etoposide—lung cancer	0.0059	0.0112	CbGbCtD
Enzalutamide—ABCB1—Docetaxel—lung cancer	0.00539	0.0102	CbGbCtD
Enzalutamide—CYP3A4—Crizotinib—lung cancer	0.00506	0.00961	CbGbCtD
Enzalutamide—CYP3A4—Erlotinib—lung cancer	0.00488	0.00927	CbGbCtD
Enzalutamide—CYP3A4—Paclitaxel—lung cancer	0.00447	0.00848	CbGbCtD
Enzalutamide—CYP3A4—Irinotecan—lung cancer	0.00441	0.00837	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—lung cancer	0.00402	0.00763	CbGbCtD
Enzalutamide—CYP3A4—Vinblastine—lung cancer	0.00392	0.00744	CbGbCtD
Enzalutamide—ABCB1—Methotrexate—lung cancer	0.0039	0.00739	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—lung cancer	0.00379	0.00719	CbGbCtD
Enzalutamide—CYP3A4—Etoposide—lung cancer	0.00353	0.0067	CbGbCtD
Enzalutamide—CYP3A4—Docetaxel—lung cancer	0.00323	0.00613	CbGbCtD
Enzalutamide—CYP3A4—Doxorubicin—lung cancer	0.00241	0.00457	CbGbCtD
Enzalutamide—Urethral disorder—Cisplatin—lung cancer	0.000225	0.00195	CcSEcCtD
Enzalutamide—Angiopathy—Gemcitabine—lung cancer	0.000223	0.00194	CcSEcCtD
Enzalutamide—Musculoskeletal pain—Doxorubicin—lung cancer	0.00022	0.0019	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Topotecan—lung cancer	0.00022	0.0019	CcSEcCtD
Enzalutamide—Fatigue—Topotecan—lung cancer	0.000219	0.0019	CcSEcCtD
Enzalutamide—Haematuria—Paclitaxel—lung cancer	0.000219	0.0019	CcSEcCtD
Enzalutamide—Sepsis—Methotrexate—lung cancer	0.000218	0.00189	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Erlotinib—lung cancer	0.000217	0.00188	CcSEcCtD
Enzalutamide—Fatigue—Erlotinib—lung cancer	0.000217	0.00188	CcSEcCtD
Enzalutamide—Epistaxis—Paclitaxel—lung cancer	0.000216	0.00188	CcSEcCtD
Enzalutamide—Infection—Vinorelbine—lung cancer	0.000216	0.00187	CcSEcCtD
Enzalutamide—Sinusitis—Paclitaxel—lung cancer	0.000215	0.00187	CcSEcCtD
Enzalutamide—Headache—Teniposide—lung cancer	0.000215	0.00186	CcSEcCtD
Enzalutamide—Nervous system disorder—Vinorelbine—lung cancer	0.000213	0.00185	CcSEcCtD
Enzalutamide—Thrombocytopenia—Vinorelbine—lung cancer	0.000213	0.00185	CcSEcCtD
Enzalutamide—Back pain—Irinotecan—lung cancer	0.000213	0.00184	CcSEcCtD
Enzalutamide—Skin disorder—Vinorelbine—lung cancer	0.000211	0.00183	CcSEcCtD
Enzalutamide—Hypoaesthesia—Etoposide—lung cancer	0.000209	0.00181	CcSEcCtD
Enzalutamide—Urinary tract disorder—Etoposide—lung cancer	0.000208	0.0018	CcSEcCtD
Enzalutamide—Back pain—Gemcitabine—lung cancer	0.000207	0.0018	CcSEcCtD
Enzalutamide—Rhinitis—Paclitaxel—lung cancer	0.000207	0.00179	CcSEcCtD
Enzalutamide—Urethral disorder—Etoposide—lung cancer	0.000206	0.00179	CcSEcCtD
Enzalutamide—Hypoaesthesia—Paclitaxel—lung cancer	0.000205	0.00178	CcSEcCtD
Enzalutamide—Pharyngitis—Paclitaxel—lung cancer	0.000204	0.00177	CcSEcCtD
Enzalutamide—Neutropenia—Docetaxel—lung cancer	0.000204	0.00177	CcSEcCtD
Enzalutamide—Urinary tract disorder—Paclitaxel—lung cancer	0.000203	0.00176	CcSEcCtD
Enzalutamide—Oedema peripheral—Paclitaxel—lung cancer	0.000203	0.00176	CcSEcCtD
Enzalutamide—Connective tissue disorder—Paclitaxel—lung cancer	0.000202	0.00176	CcSEcCtD
Enzalutamide—Urethral disorder—Paclitaxel—lung cancer	0.000202	0.00175	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000198	0.00172	CcSEcCtD
Enzalutamide—Vertigo—Irinotecan—lung cancer	0.000198	0.00171	CcSEcCtD
Enzalutamide—Leukopenia—Irinotecan—lung cancer	0.000197	0.00171	CcSEcCtD
Enzalutamide—Pneumonia—Docetaxel—lung cancer	0.000196	0.0017	CcSEcCtD
Enzalutamide—Paraesthesia—Vinorelbine—lung cancer	0.000195	0.00169	CcSEcCtD
Enzalutamide—Infestation NOS—Docetaxel—lung cancer	0.000195	0.00169	CcSEcCtD
Enzalutamide—Infestation—Docetaxel—lung cancer	0.000195	0.00169	CcSEcCtD
Enzalutamide—Leukopenia—Gemcitabine—lung cancer	0.000192	0.00166	CcSEcCtD
Enzalutamide—Angiopathy—Etoposide—lung cancer	0.000191	0.00165	CcSEcCtD
Enzalutamide—Hypertension—Irinotecan—lung cancer	0.00019	0.00165	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—lung cancer	0.000188	0.00163	CcSEcCtD
Enzalutamide—Asthenia—Vinblastine—lung cancer	0.000188	0.00163	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000188	0.00163	CcSEcCtD
Enzalutamide—Fatigue—Vinorelbine—lung cancer	0.000188	0.00163	CcSEcCtD
Enzalutamide—Angiopathy—Paclitaxel—lung cancer	0.000187	0.00162	CcSEcCtD
Enzalutamide—Hypertension—Gemcitabine—lung cancer	0.000185	0.0016	CcSEcCtD
Enzalutamide—Epistaxis—Docetaxel—lung cancer	0.000183	0.00159	CcSEcCtD
Enzalutamide—Asthenia—Topotecan—lung cancer	0.000183	0.00158	CcSEcCtD
Enzalutamide—Arthralgia—Gemcitabine—lung cancer	0.000182	0.00158	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000181	0.00157	CcSEcCtD
Enzalutamide—Asthenia—Erlotinib—lung cancer	0.000181	0.00157	CcSEcCtD
Enzalutamide—Mental disorder—Paclitaxel—lung cancer	0.000181	0.00157	CcSEcCtD
Enzalutamide—Pruritus—Topotecan—lung cancer	0.00018	0.00156	CcSEcCtD
Enzalutamide—Diarrhoea—Vinblastine—lung cancer	0.000179	0.00155	CcSEcCtD
Enzalutamide—Leukopenia—Cisplatin—lung cancer	0.000179	0.00155	CcSEcCtD
Enzalutamide—Infection—Irinotecan—lung cancer	0.000178	0.00155	CcSEcCtD
Enzalutamide—Pruritus—Erlotinib—lung cancer	0.000178	0.00154	CcSEcCtD
Enzalutamide—Back pain—Etoposide—lung cancer	0.000177	0.00153	CcSEcCtD
Enzalutamide—Nervous system disorder—Irinotecan—lung cancer	0.000176	0.00153	CcSEcCtD
Enzalutamide—Thrombocytopenia—Irinotecan—lung cancer	0.000176	0.00152	CcSEcCtD
Enzalutamide—Rhinitis—Docetaxel—lung cancer	0.000175	0.00152	CcSEcCtD
Enzalutamide—Diarrhoea—Topotecan—lung cancer	0.000174	0.00151	CcSEcCtD
Enzalutamide—Hypoaesthesia—Docetaxel—lung cancer	0.000174	0.00151	CcSEcCtD
Enzalutamide—Infection—Gemcitabine—lung cancer	0.000174	0.00151	CcSEcCtD
Enzalutamide—Back pain—Paclitaxel—lung cancer	0.000173	0.0015	CcSEcCtD
Enzalutamide—Pharyngitis—Docetaxel—lung cancer	0.000173	0.0015	CcSEcCtD
Enzalutamide—Dizziness—Vinblastine—lung cancer	0.000173	0.0015	CcSEcCtD
Enzalutamide—Convulsion—Cisplatin—lung cancer	0.000173	0.0015	CcSEcCtD
Enzalutamide—Urinary tract disorder—Docetaxel—lung cancer	0.000172	0.0015	CcSEcCtD
Enzalutamide—Diarrhoea—Erlotinib—lung cancer	0.000172	0.00149	CcSEcCtD
Enzalutamide—Oedema peripheral—Docetaxel—lung cancer	0.000172	0.00149	CcSEcCtD
Enzalutamide—Connective tissue disorder—Docetaxel—lung cancer	0.000172	0.00149	CcSEcCtD
Enzalutamide—Nervous system disorder—Gemcitabine—lung cancer	0.000171	0.00149	CcSEcCtD
Enzalutamide—Urethral disorder—Docetaxel—lung cancer	0.000171	0.00148	CcSEcCtD
Enzalutamide—Thrombocytopenia—Gemcitabine—lung cancer	0.000171	0.00148	CcSEcCtD
Enzalutamide—Skin disorder—Gemcitabine—lung cancer	0.00017	0.00147	CcSEcCtD
Enzalutamide—Anxiety—Cisplatin—lung cancer	0.000169	0.00147	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000169	0.00146	CcSEcCtD
Enzalutamide—Hot flush—Doxorubicin—lung cancer	0.000168	0.00146	CcSEcCtD
Enzalutamide—Dizziness—Topotecan—lung cancer	0.000168	0.00146	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—lung cancer	0.000167	0.00145	CcSEcCtD
Enzalutamide—Dizziness—Erlotinib—lung cancer	0.000166	0.00144	CcSEcCtD
Enzalutamide—Vertigo—Etoposide—lung cancer	0.000164	0.00143	CcSEcCtD
Enzalutamide—Headache—Vinblastine—lung cancer	0.000164	0.00142	CcSEcCtD
Enzalutamide—Leukopenia—Etoposide—lung cancer	0.000164	0.00142	CcSEcCtD
Enzalutamide—Insomnia—Irinotecan—lung cancer	0.000162	0.00141	CcSEcCtD
Enzalutamide—Infection—Cisplatin—lung cancer	0.000162	0.0014	CcSEcCtD
Enzalutamide—Paraesthesia—Irinotecan—lung cancer	0.000161	0.0014	CcSEcCtD
Enzalutamide—Vertigo—Paclitaxel—lung cancer	0.000161	0.0014	CcSEcCtD
Enzalutamide—Leukopenia—Paclitaxel—lung cancer	0.000161	0.00139	CcSEcCtD
Enzalutamide—Nervous system disorder—Cisplatin—lung cancer	0.00016	0.00139	CcSEcCtD
Enzalutamide—Thrombocytopenia—Cisplatin—lung cancer	0.00016	0.00138	CcSEcCtD
Enzalutamide—Headache—Topotecan—lung cancer	0.000159	0.00138	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000159	0.00138	CcSEcCtD
Enzalutamide—Convulsion—Etoposide—lung cancer	0.000158	0.00137	CcSEcCtD
Enzalutamide—Angiopathy—Docetaxel—lung cancer	0.000158	0.00137	CcSEcCtD
Enzalutamide—Skin disorder—Cisplatin—lung cancer	0.000158	0.00137	CcSEcCtD
Enzalutamide—Insomnia—Gemcitabine—lung cancer	0.000158	0.00137	CcSEcCtD
Enzalutamide—Hypertension—Etoposide—lung cancer	0.000158	0.00137	CcSEcCtD
Enzalutamide—Headache—Erlotinib—lung cancer	0.000158	0.00137	CcSEcCtD
Enzalutamide—Paraesthesia—Gemcitabine—lung cancer	0.000157	0.00136	CcSEcCtD
Enzalutamide—Asthenia—Vinorelbine—lung cancer	0.000156	0.00135	CcSEcCtD
Enzalutamide—Convulsion—Paclitaxel—lung cancer	0.000155	0.00135	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000155	0.00134	CcSEcCtD
Enzalutamide—Hypertension—Paclitaxel—lung cancer	0.000155	0.00134	CcSEcCtD
Enzalutamide—Fatigue—Irinotecan—lung cancer	0.000155	0.00134	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000155	0.00134	CcSEcCtD
Enzalutamide—Pruritus—Vinorelbine—lung cancer	0.000154	0.00134	CcSEcCtD
Enzalutamide—Mental disorder—Docetaxel—lung cancer	0.000153	0.00133	CcSEcCtD
Enzalutamide—Arthralgia—Paclitaxel—lung cancer	0.000153	0.00132	CcSEcCtD
Enzalutamide—Anxiety—Paclitaxel—lung cancer	0.000152	0.00132	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000152	0.00131	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000151	0.00131	CcSEcCtD
Enzalutamide—Fatigue—Gemcitabine—lung cancer	0.000151	0.00131	CcSEcCtD
Enzalutamide—Diarrhoea—Vinorelbine—lung cancer	0.000149	0.00129	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000148	0.00129	CcSEcCtD
Enzalutamide—Infection—Etoposide—lung cancer	0.000148	0.00129	CcSEcCtD
Enzalutamide—Back pain—Docetaxel—lung cancer	0.000147	0.00128	CcSEcCtD
Enzalutamide—Neutropenia—Methotrexate—lung cancer	0.000147	0.00128	CcSEcCtD
Enzalutamide—Paraesthesia—Cisplatin—lung cancer	0.000146	0.00127	CcSEcCtD
Enzalutamide—Thrombocytopenia—Etoposide—lung cancer	0.000146	0.00127	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Methotrexate—lung cancer	0.000146	0.00127	CcSEcCtD
Enzalutamide—Infection—Paclitaxel—lung cancer	0.000145	0.00126	CcSEcCtD
Enzalutamide—Skin disorder—Etoposide—lung cancer	0.000145	0.00126	CcSEcCtD
Enzalutamide—Dry skin—Doxorubicin—lung cancer	0.000144	0.00125	CcSEcCtD
Enzalutamide—Dizziness—Vinorelbine—lung cancer	0.000144	0.00125	CcSEcCtD
Enzalutamide—Nervous system disorder—Paclitaxel—lung cancer	0.000144	0.00124	CcSEcCtD
Enzalutamide—Thrombocytopenia—Paclitaxel—lung cancer	0.000143	0.00124	CcSEcCtD
Enzalutamide—Skin disorder—Paclitaxel—lung cancer	0.000142	0.00123	CcSEcCtD
Enzalutamide—Pneumonia—Methotrexate—lung cancer	0.000141	0.00122	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—lung cancer	0.000141	0.00122	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000141	0.00122	CcSEcCtD
Enzalutamide—Infestation—Methotrexate—lung cancer	0.00014	0.00122	CcSEcCtD
Enzalutamide—Infestation NOS—Methotrexate—lung cancer	0.00014	0.00122	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—lung cancer	0.000139	0.0012	CcSEcCtD
Enzalutamide—Headache—Vinorelbine—lung cancer	0.000136	0.00118	CcSEcCtD
Enzalutamide—Leukopenia—Docetaxel—lung cancer	0.000136	0.00118	CcSEcCtD
Enzalutamide—Paraesthesia—Etoposide—lung cancer	0.000134	0.00116	CcSEcCtD
Enzalutamide—Haematuria—Methotrexate—lung cancer	0.000134	0.00116	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000133	0.00116	CcSEcCtD
Enzalutamide—Insomnia—Paclitaxel—lung cancer	0.000132	0.00115	CcSEcCtD
Enzalutamide—Epistaxis—Methotrexate—lung cancer	0.000132	0.00115	CcSEcCtD
Enzalutamide—Convulsion—Docetaxel—lung cancer	0.000132	0.00114	CcSEcCtD
Enzalutamide—Paraesthesia—Paclitaxel—lung cancer	0.000131	0.00114	CcSEcCtD
Enzalutamide—Hypertension—Docetaxel—lung cancer	0.000131	0.00114	CcSEcCtD
Enzalutamide—Bronchitis—Doxorubicin—lung cancer	0.000131	0.00114	CcSEcCtD
Enzalutamide—Arthralgia—Docetaxel—lung cancer	0.000129	0.00112	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Etoposide—lung cancer	0.000129	0.00112	CcSEcCtD
Enzalutamide—Asthenia—Irinotecan—lung cancer	0.000129	0.00112	CcSEcCtD
Enzalutamide—Fatigue—Etoposide—lung cancer	0.000129	0.00112	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000129	0.00111	CcSEcCtD
Enzalutamide—Neutropenia—Doxorubicin—lung cancer	0.000127	0.0011	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000127	0.0011	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000126	0.0011	CcSEcCtD
Enzalutamide—Fatigue—Paclitaxel—lung cancer	0.000126	0.00109	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—lung cancer	0.000126	0.00109	CcSEcCtD
Enzalutamide—Asthenia—Gemcitabine—lung cancer	0.000125	0.00109	CcSEcCtD
Enzalutamide—Pharyngitis—Methotrexate—lung cancer	0.000125	0.00108	CcSEcCtD
Enzalutamide—Urinary tract disorder—Methotrexate—lung cancer	0.000124	0.00108	CcSEcCtD
Enzalutamide—Pruritus—Gemcitabine—lung cancer	0.000124	0.00107	CcSEcCtD
Enzalutamide—Urethral disorder—Methotrexate—lung cancer	0.000123	0.00107	CcSEcCtD
Enzalutamide—Infection—Docetaxel—lung cancer	0.000123	0.00107	CcSEcCtD
Enzalutamide—Diarrhoea—Irinotecan—lung cancer	0.000123	0.00106	CcSEcCtD
Enzalutamide—Pneumonia—Doxorubicin—lung cancer	0.000122	0.00106	CcSEcCtD
Enzalutamide—Nervous system disorder—Docetaxel—lung cancer	0.000122	0.00106	CcSEcCtD
Enzalutamide—Thrombocytopenia—Docetaxel—lung cancer	0.000121	0.00105	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—lung cancer	0.000121	0.00105	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—lung cancer	0.000121	0.00105	CcSEcCtD
Enzalutamide—Skin disorder—Docetaxel—lung cancer	0.000121	0.00105	CcSEcCtD
Enzalutamide—Diarrhoea—Gemcitabine—lung cancer	0.00012	0.00104	CcSEcCtD
Enzalutamide—Dizziness—Irinotecan—lung cancer	0.000119	0.00103	CcSEcCtD
Enzalutamide—Asthenia—Cisplatin—lung cancer	0.000117	0.00101	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—lung cancer	0.000116	0.001	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—lung cancer	0.000115	0.000993	CcSEcCtD
Enzalutamide—Angiopathy—Methotrexate—lung cancer	0.000114	0.00099	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—lung cancer	0.000114	0.000988	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000113	0.00098	CcSEcCtD
Enzalutamide—Headache—Irinotecan—lung cancer	0.000112	0.000975	CcSEcCtD
Enzalutamide—Insomnia—Docetaxel—lung cancer	0.000112	0.000973	CcSEcCtD
Enzalutamide—Diarrhoea—Cisplatin—lung cancer	0.000111	0.000967	CcSEcCtD
Enzalutamide—Paraesthesia—Docetaxel—lung cancer	0.000111	0.000966	CcSEcCtD
Enzalutamide—Mental disorder—Methotrexate—lung cancer	0.00011	0.000956	CcSEcCtD
Enzalutamide—Headache—Gemcitabine—lung cancer	0.00011	0.00095	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—lung cancer	0.000109	0.000947	CcSEcCtD
Enzalutamide—Hypoaesthesia—Doxorubicin—lung cancer	0.000108	0.00094	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—lung cancer	0.000108	0.000938	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—lung cancer	0.000108	0.000933	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—lung cancer	0.000107	0.000931	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000107	0.000929	CcSEcCtD
Enzalutamide—Asthenia—Etoposide—lung cancer	0.000107	0.000929	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—lung cancer	0.000107	0.000929	CcSEcCtD
Enzalutamide—Fatigue—Docetaxel—lung cancer	0.000107	0.000928	CcSEcCtD
Enzalutamide—Urethral disorder—Doxorubicin—lung cancer	0.000107	0.000926	CcSEcCtD
Enzalutamide—Back pain—Methotrexate—lung cancer	0.000106	0.000919	CcSEcCtD
Enzalutamide—Pruritus—Etoposide—lung cancer	0.000106	0.000916	CcSEcCtD
Enzalutamide—Asthenia—Paclitaxel—lung cancer	0.000105	0.000911	CcSEcCtD
Enzalutamide—Pruritus—Paclitaxel—lung cancer	0.000104	0.000898	CcSEcCtD
Enzalutamide—Diarrhoea—Etoposide—lung cancer	0.000102	0.000886	CcSEcCtD
Enzalutamide—Diarrhoea—Paclitaxel—lung cancer	0.0001	0.000868	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—lung cancer	9.89e-05	0.000857	CcSEcCtD
Enzalutamide—Dizziness—Etoposide—lung cancer	9.87e-05	0.000856	CcSEcCtD
Enzalutamide—Vertigo—Methotrexate—lung cancer	9.84e-05	0.000854	CcSEcCtD
Enzalutamide—Leukopenia—Methotrexate—lung cancer	9.81e-05	0.00085	CcSEcCtD
Enzalutamide—Dizziness—Paclitaxel—lung cancer	9.68e-05	0.000839	CcSEcCtD
Enzalutamide—Mental disorder—Doxorubicin—lung cancer	9.55e-05	0.000828	CcSEcCtD
Enzalutamide—Convulsion—Methotrexate—lung cancer	9.49e-05	0.000823	CcSEcCtD
Enzalutamide—Headache—Etoposide—lung cancer	9.35e-05	0.000811	CcSEcCtD
Enzalutamide—Arthralgia—Methotrexate—lung cancer	9.33e-05	0.000809	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.26e-05	0.000803	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—lung cancer	9.18e-05	0.000796	CcSEcCtD
Enzalutamide—Headache—Paclitaxel—lung cancer	9.17e-05	0.000795	CcSEcCtD
Enzalutamide—Asthenia—Docetaxel—lung cancer	8.9e-05	0.000772	CcSEcCtD
Enzalutamide—Infection—Methotrexate—lung cancer	8.88e-05	0.00077	CcSEcCtD
Enzalutamide—Pruritus—Docetaxel—lung cancer	8.78e-05	0.000761	CcSEcCtD
Enzalutamide—Nervous system disorder—Methotrexate—lung cancer	8.77e-05	0.00076	CcSEcCtD
Enzalutamide—Thrombocytopenia—Methotrexate—lung cancer	8.76e-05	0.000759	CcSEcCtD
Enzalutamide—Skin disorder—Methotrexate—lung cancer	8.69e-05	0.000753	CcSEcCtD
Enzalutamide—Vertigo—Doxorubicin—lung cancer	8.52e-05	0.000739	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—lung cancer	8.49e-05	0.000736	CcSEcCtD
Enzalutamide—Diarrhoea—Docetaxel—lung cancer	8.49e-05	0.000736	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—lung cancer	8.22e-05	0.000713	CcSEcCtD
Enzalutamide—Dizziness—Docetaxel—lung cancer	8.2e-05	0.000711	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—lung cancer	8.19e-05	0.00071	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methotrexate—lung cancer	8.15e-05	0.000706	CcSEcCtD
Enzalutamide—Insomnia—Methotrexate—lung cancer	8.09e-05	0.000701	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—lung cancer	8.08e-05	0.0007	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—lung cancer	8.05e-05	0.000698	CcSEcCtD
Enzalutamide—Paraesthesia—Methotrexate—lung cancer	8.03e-05	0.000696	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.02e-05	0.000696	CcSEcCtD
Enzalutamide—Headache—Docetaxel—lung cancer	7.77e-05	0.000674	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Methotrexate—lung cancer	7.72e-05	0.000669	CcSEcCtD
Enzalutamide—Fatigue—Methotrexate—lung cancer	7.71e-05	0.000669	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—lung cancer	7.69e-05	0.000667	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—lung cancer	7.59e-05	0.000658	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—lung cancer	7.58e-05	0.000657	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—lung cancer	7.52e-05	0.000652	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.05e-05	0.000612	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—lung cancer	7e-05	0.000607	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—lung cancer	6.95e-05	0.000603	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—lung cancer	6.69e-05	0.00058	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—lung cancer	6.68e-05	0.000579	CcSEcCtD
Enzalutamide—Asthenia—Methotrexate—lung cancer	6.42e-05	0.000556	CcSEcCtD
Enzalutamide—Pruritus—Methotrexate—lung cancer	6.33e-05	0.000549	CcSEcCtD
Enzalutamide—Diarrhoea—Methotrexate—lung cancer	6.12e-05	0.000531	CcSEcCtD
Enzalutamide—Dizziness—Methotrexate—lung cancer	5.91e-05	0.000513	CcSEcCtD
Enzalutamide—Headache—Methotrexate—lung cancer	5.6e-05	0.000486	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—lung cancer	5.56e-05	0.000482	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—lung cancer	5.48e-05	0.000475	CcSEcCtD
Enzalutamide—Diarrhoea—Doxorubicin—lung cancer	5.3e-05	0.000459	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—lung cancer	5.12e-05	0.000444	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—lung cancer	4.85e-05	0.000421	CcSEcCtD
Enzalutamide—CYP2C9—Metabolism—GSTT1—lung cancer	6.57e-06	7.5e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.57e-06	7.5e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GCLC—lung cancer	6.55e-06	7.48e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2A6—lung cancer	6.55e-06	7.48e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.53e-06	7.46e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.5e-06	7.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GCLC—lung cancer	6.49e-06	7.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2A6—lung cancer	6.49e-06	7.41e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.47e-06	7.39e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.47e-06	7.39e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTP1—lung cancer	6.46e-06	7.38e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CAT—lung cancer	6.43e-06	7.34e-05	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	6.36e-06	7.26e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CAT—lung cancer	6.28e-06	7.18e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ABCB1—lung cancer	6.25e-06	7.14e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ENO1—lung cancer	6.21e-06	7.09e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—B4GALT5—lung cancer	6.18e-06	7.05e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	6.16e-06	7.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ENO1—lung cancer	6.15e-06	7.03e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TYMS—lung cancer	6.14e-06	7.02e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.13e-06	7e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ABCB1—lung cancer	6.11e-06	6.98e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTM1—lung cancer	6.07e-06	6.93e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP2E1—lung cancer	6.05e-06	6.91e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.05e-06	6.91e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—STK11—lung cancer	6.04e-06	6.9e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—STK11—lung cancer	6.01e-06	6.87e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTA4—lung cancer	6.01e-06	6.86e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TYMS—lung cancer	6e-06	6.86e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NQO1—lung cancer	5.98e-06	6.84e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MAPK3—lung cancer	5.93e-06	6.78e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTM1—lung cancer	5.93e-06	6.78e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—EP300—lung cancer	5.91e-06	6.75e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP2E1—lung cancer	5.91e-06	6.75e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.86e-06	6.69e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTA2—lung cancer	5.85e-06	6.69e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NQO1—lung cancer	5.84e-06	6.67e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.81e-06	6.63e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MYC—lung cancer	5.77e-06	6.59e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP1A1—lung cancer	5.75e-06	6.57e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SRC—lung cancer	5.75e-06	6.56e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ERCC2—lung cancer	5.71e-06	6.52e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.67e-06	6.48e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTA1—lung cancer	5.65e-06	6.45e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.64e-06	6.44e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP1A1—lung cancer	5.62e-06	6.43e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—lung cancer	5.6e-06	6.39e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTP1—lung cancer	5.59e-06	6.39e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCC3—lung cancer	5.58e-06	6.38e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ERCC2—lung cancer	5.58e-06	6.37e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.57e-06	6.36e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2E1—lung cancer	5.57e-06	6.36e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTP1—lung cancer	5.56e-06	6.35e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NRAS—lung cancer	5.53e-06	6.32e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2E1—lung cancer	5.52e-06	6.3e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NQO1—lung cancer	5.5e-06	6.29e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NQO1—lung cancer	5.46e-06	6.23e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CAT—lung cancer	5.44e-06	6.22e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CAT—lung cancer	5.41e-06	6.18e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.41e-06	6.18e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1C1—lung cancer	5.41e-06	6.18e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—STK11—lung cancer	5.39e-06	6.16e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.38e-06	6.15e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.34e-06	6.1e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.29e-06	6.05e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK3—lung cancer	5.29e-06	6.05e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ABCB1—lung cancer	5.29e-06	6.05e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—STK11—lung cancer	5.27e-06	6.02e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ABCB1—lung cancer	5.26e-06	6.01e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—UGT1A1—lung cancer	5.25e-06	6e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TYMS—lung cancer	5.2e-06	5.94e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TYMS—lung cancer	5.17e-06	5.91e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—lung cancer	5.14e-06	5.87e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—lung cancer	5.11e-06	5.84e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.06e-06	5.79e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GNG11—lung cancer	5.06e-06	5.78e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTP1—lung cancer	4.99e-06	5.7e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—STK11—lung cancer	4.96e-06	5.67e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOA1—lung cancer	4.94e-06	5.64e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—STK11—lung cancer	4.92e-06	5.62e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTP1—lung cancer	4.87e-06	5.57e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP1A1—lung cancer	4.87e-06	5.57e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CAT—lung cancer	4.86e-06	5.55e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP1A1—lung cancer	4.84e-06	5.53e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ERCC2—lung cancer	4.83e-06	5.52e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.83e-06	5.52e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOA1—lung cancer	4.83e-06	5.51e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDOA—lung cancer	4.82e-06	5.51e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ERCC2—lung cancer	4.8e-06	5.49e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KRAS—lung cancer	4.76e-06	5.44e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CAT—lung cancer	4.74e-06	5.42e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ABCB1—lung cancer	4.72e-06	5.4e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NCOA3—lung cancer	4.68e-06	5.35e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TYMS—lung cancer	4.64e-06	5.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.62e-06	5.27e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTP1—lung cancer	4.59e-06	5.24e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—lung cancer	4.59e-06	5.24e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCG2—lung cancer	4.55e-06	5.2e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ADCY1—lung cancer	4.55e-06	5.2e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTP1—lung cancer	4.55e-06	5.2e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TYMS—lung cancer	4.53e-06	5.17e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CG—lung cancer	4.51e-06	5.15e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—lung cancer	4.48e-06	5.11e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CAT—lung cancer	4.47e-06	5.1e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ENO2—lung cancer	4.46e-06	5.1e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HPGDS—lung cancer	4.46e-06	5.1e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.44e-06	5.07e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CAT—lung cancer	4.43e-06	5.06e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CG—lung cancer	4.41e-06	5.03e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.4e-06	5.03e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—lung cancer	4.37e-06	4.99e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP1A1—lung cancer	4.35e-06	4.97e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ABCB1—lung cancer	4.35e-06	4.96e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTT1—lung cancer	4.33e-06	4.95e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ERCC2—lung cancer	4.31e-06	4.93e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ABCB1—lung cancer	4.31e-06	4.92e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—POMC—lung cancer	4.29e-06	4.9e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GCLC—lung cancer	4.28e-06	4.89e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2A6—lung cancer	4.28e-06	4.89e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TYMS—lung cancer	4.27e-06	4.88e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP1A1—lung cancer	4.24e-06	4.85e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TYMS—lung cancer	4.23e-06	4.83e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—lung cancer	4.23e-06	4.83e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—lung cancer	4.22e-06	4.82e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ERCC2—lung cancer	4.21e-06	4.81e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—POMC—lung cancer	4.19e-06	4.79e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—lung cancer	4.18e-06	4.78e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOA1—lung cancer	4.18e-06	4.77e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CREBBP—lung cancer	4.18e-06	4.77e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOA1—lung cancer	4.16e-06	4.75e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CREBBP—lung cancer	4.08e-06	4.67e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ENO1—lung cancer	4.06e-06	4.64e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HRAS—lung cancer	4.04e-06	4.62e-05	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—AKT1—lung cancer	4e-06	4.57e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4e-06	4.57e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP1A1—lung cancer	4e-06	4.57e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.98e-06	4.55e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ERCC2—lung cancer	3.97e-06	4.53e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP1A1—lung cancer	3.96e-06	4.53e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CD—lung cancer	3.96e-06	4.53e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ERCC2—lung cancer	3.93e-06	4.49e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—lung cancer	3.91e-06	4.47e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CD—lung cancer	3.87e-06	4.42e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—lung cancer	3.82e-06	4.37e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CG—lung cancer	3.82e-06	4.36e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CG—lung cancer	3.79e-06	4.33e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOA1—lung cancer	3.73e-06	4.26e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOA1—lung cancer	3.64e-06	4.16e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2E1—lung cancer	3.64e-06	4.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—POMC—lung cancer	3.63e-06	4.15e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—POMC—lung cancer	3.61e-06	4.13e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NQO1—lung cancer	3.6e-06	4.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.57e-06	4.08e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—AKT1—lung cancer	3.57e-06	4.08e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CREBBP—lung cancer	3.54e-06	4.04e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CREBBP—lung cancer	3.52e-06	4.02e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CB—lung cancer	3.45e-06	3.95e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOA1—lung cancer	3.43e-06	3.92e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—lung cancer	3.42e-06	3.91e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CG—lung cancer	3.41e-06	3.89e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOA1—lung cancer	3.4e-06	3.89e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CB—lung cancer	3.38e-06	3.86e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CD—lung cancer	3.35e-06	3.83e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—lung cancer	3.34e-06	3.82e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CD—lung cancer	3.34e-06	3.81e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CG—lung cancer	3.32e-06	3.8e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—lung cancer	3.31e-06	3.78e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.26e-06	3.72e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—STK11—lung cancer	3.24e-06	3.71e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—POMC—lung cancer	3.24e-06	3.7e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—POMC—lung cancer	3.16e-06	3.62e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CREBBP—lung cancer	3.16e-06	3.61e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CG—lung cancer	3.13e-06	3.58e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CG—lung cancer	3.11e-06	3.55e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CREBBP—lung cancer	3.08e-06	3.52e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTP1—lung cancer	3e-06	3.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CD—lung cancer	2.99e-06	3.42e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTEN—lung cancer	2.98e-06	3.41e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—POMC—lung cancer	2.98e-06	3.41e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—POMC—lung cancer	2.96e-06	3.38e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—lung cancer	2.96e-06	3.38e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CB—lung cancer	2.92e-06	3.34e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CD—lung cancer	2.92e-06	3.34e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CAT—lung cancer	2.92e-06	3.34e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTEN—lung cancer	2.92e-06	3.33e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CB—lung cancer	2.91e-06	3.32e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CREBBP—lung cancer	2.9e-06	3.32e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—lung cancer	2.9e-06	3.31e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—lung cancer	2.88e-06	3.3e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—lung cancer	2.88e-06	3.29e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CREBBP—lung cancer	2.88e-06	3.29e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—EP300—lung cancer	2.85e-06	3.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ABCB1—lung cancer	2.84e-06	3.25e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TYMS—lung cancer	2.79e-06	3.19e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—EP300—lung cancer	2.78e-06	3.18e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—lung cancer	2.76e-06	3.15e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CD—lung cancer	2.75e-06	3.15e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CD—lung cancer	2.73e-06	3.12e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—lung cancer	2.72e-06	3.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—lung cancer	2.69e-06	3.08e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP1A1—lung cancer	2.61e-06	2.99e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CB—lung cancer	2.61e-06	2.98e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ERCC2—lung cancer	2.59e-06	2.96e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—lung cancer	2.59e-06	2.95e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CB—lung cancer	2.55e-06	2.91e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTEN—lung cancer	2.53e-06	2.89e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—lung cancer	2.52e-06	2.88e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTEN—lung cancer	2.51e-06	2.87e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—EP300—lung cancer	2.41e-06	2.75e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CB—lung cancer	2.4e-06	2.74e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—EP300—lung cancer	2.4e-06	2.74e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CB—lung cancer	2.38e-06	2.72e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—lung cancer	2.38e-06	2.72e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—lung cancer	2.36e-06	2.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTEN—lung cancer	2.26e-06	2.58e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA1—lung cancer	2.24e-06	2.56e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTEN—lung cancer	2.2e-06	2.51e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—EP300—lung cancer	2.15e-06	2.46e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—lung cancer	2.11e-06	2.41e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—EP300—lung cancer	2.1e-06	2.4e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTEN—lung cancer	2.07e-06	2.37e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—lung cancer	2.06e-06	2.35e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTEN—lung cancer	2.06e-06	2.35e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CG—lung cancer	2.05e-06	2.34e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—EP300—lung cancer	1.98e-06	2.26e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—EP300—lung cancer	1.96e-06	2.24e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—POMC—lung cancer	1.95e-06	2.23e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CREBBP—lung cancer	1.9e-06	2.17e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CD—lung cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—lung cancer	1.78e-06	2.04e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—lung cancer	1.78e-06	2.03e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—lung cancer	1.77e-06	2.02e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKT1—lung cancer	1.72e-06	1.96e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKT1—lung cancer	1.68e-06	1.92e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—lung cancer	1.59e-06	1.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CB—lung cancer	1.57e-06	1.79e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—lung cancer	1.55e-06	1.78e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—lung cancer	1.55e-06	1.77e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—lung cancer	1.46e-06	1.67e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKT1—lung cancer	1.46e-06	1.66e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—lung cancer	1.45e-06	1.66e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKT1—lung cancer	1.45e-06	1.65e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTEN—lung cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKT1—lung cancer	1.3e-06	1.48e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—EP300—lung cancer	1.29e-06	1.48e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKT1—lung cancer	1.27e-06	1.45e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKT1—lung cancer	1.2e-06	1.37e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKT1—lung cancer	1.19e-06	1.35e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—lung cancer	9.57e-07	1.09e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKT1—lung cancer	7.82e-07	8.93e-06	CbGpPWpGaD
